References
- Beck W. T. The cell biology of multiple drug resistance. Biochem. Pharmacol. 1987; 36: 2879
- Sadavisan R., Morgan R., Fabian C., Stephens R. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin. Cancer Lett. 1991; 57: 165
- Thierry A. R., Dritschilo A., Rahman A. Effect of liposomes on P-glycoprotein function in multidrug resistant cells. Biochem. Biophys. Res. Comm. 1992; 187: 1098
- Mickish G. H., Rahman A., Pastan I., Gottesman M. Increased effectiveness of liosome-encapsulated doxorubicin in multidrug resistance- transgenic mice compared with free doxorubicin. J. Natl Cancer Institute. 1992; 84: 804
- Horowitz A. T., Barenholz Y., Gabizon A. A. In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome concentration and drug release. Biochim. Biophys. Acta 1992; 1109: 203
- Cuvier C., Roblot-Treupel L., Millot J. M., Lizard G., Chevillard S., Manfait M., Couvreur P., Poupon M. F. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem. Pharmacol. 1992; 44: 509
- Henry-Toulmé N., Decout A., Lalanne J., Nemati F., Dubernet C., Dufourcq J. Probing the interaction of the anticancer drug doxorubicin with polymeric nanoparticles using fluorescence spectroscopy. J. Colloids Int. Science 1993, in press
- Mayer L. D., Tai L. C. L., Bally M. B., Mitilenes G. N., Ginsberg R. S., Cullis P. R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradient. Biochim. Biophys. Acta 1990; 1025: 143
- Singleton W. S., Gray M. S., Brown M. L., Whick J. L. J. Am. Chem. Soc. 1965; 42: 53
- Ruggiero J., Xodo L. E., Ciana A., Manzini G., Quadfrifoglio F. Charge effects in the interaction of doxorubicin and derivatives with polydeoxynucleotides. Biochim. Biophys. Acta 1992; 1129: 294
- Vist M. R., Davis J. H. Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry. Biochemistry. 1990; 29: 451